2014
DOI: 10.1155/2014/974154
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Spontaneous Urticaria Is Characterized by Lower Serum Advanced Glycation End-Products

Abstract: Background. Chronic spontaneous urticaria (CSU) is associated with activation of acute phase response. On the other hand, it is known that systemic inflammation may lead to increased formation of advanced glycation end-products (AGEs), associated with pathogenesis of various diseases. Aim. We aim to test whether chronic inflammation manifested by activated acute phase response may provide a mechanism for increased serum AGEs concentration in CSU. Methods. Concentrations of AGEs were measured spectrofluorimetri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
3

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(15 citation statements)
references
References 23 publications
0
12
3
Order By: Relevance
“…37 patients with active CSU (26 women and 11 men; mean age: 39 ± 9.5 years) with a median disease duration of 2.9 years were enrolled in the study, as described previously [ 13 ].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…37 patients with active CSU (26 women and 11 men; mean age: 39 ± 9.5 years) with a median disease duration of 2.9 years were enrolled in the study, as described previously [ 13 ].…”
Section: Methodsmentioning
confidence: 99%
“…CRP concentration in moderate-severe CSU group was significantly higher than in mild CSU group and the healthy subjects (median 10.30 vs. 1.2 vs. 1.02 mg/l, p < 0.00001). There was no significant difference in serum CRP concentration between patients with mild CSU and the control group (median 1.2 vs. 1.02 mg/l, p = 0.07) [ 13 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, serum AGE concentrations in chronic spontaneous urticarial (CSU) patients were significantly lower as compared with the healthy subjects [19]. Plasma soluble receptor for advanced glycation end products (sRAGE) may serve as a potential biomarker for disease activity and a future therapeutic target in systemic lupus erythematosus (SLE) [20].…”
Section: Introductionmentioning
confidence: 99%
“…Studies on animals have shown that the levels of the glycation product N-e-fructose lysine (FL) and CML identified by GC/MS in liver proteins decreased significantly in hyperthyroid rats, proving that thyroid hormones influence this process [21]. Due to the increasing interest in the usage of various receptors for advanced glycation end products (RAGE) (especially those being expressed on the surface of monocytes) as potential therapeutic targets in the states of inflammation and autoimmunisation [20], like GO, it is essential to examine the process of glycation in that state.…”
Section: Introductionmentioning
confidence: 99%